US 11161906
Multispecific antibodies, multispecific activatable antibodies and methods of using the same
granted A61PA61P35/00
Quick answer
US patent 11161906 (Multispecific antibodies, multispecific activatable antibodies and methods of using the same) held by CytomX Therapeutics, Inc. expires Mon Oct 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CytomX Therapeutics, Inc.
- Grant date
- Tue Nov 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 45
- CPC classes
- A61P, A61P35/00